Skip to evidence report

Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.

Type: neuron: cell membership

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

Scope ID: neuron · type

All-cell scope membership reference

Cell-identity scopes include only populations at the same or a finer hierarchy level: parent populations do not list their child identity scopes. Overview, tissue, system, lineage and theme scopes use positive full-cell overlap; overlap does not imply that a population is wholly contained in that scope. Membership uses canonical names and levels from the full atlas, never sampled UMAP cells or legacy scoped aliases. Counts below are full-atlas population counts, not scope-local counts. Scope membership does not recompute or change the all-tissue ranking scores.

Type (L1)

1 canonical populations.

Type: neuron — Type (L1)
BrowsersCell populationFull atlas cell countCell-to-scope referenceMeta traits (Specific)Individual traits (Specific)
neuron17,835All scopes3301,328

Subtype (L1S)

7 canonical populations.

Type: neuron — Subtype (L1S)
BrowsersCell populationFull atlas cell countCell-to-scope referenceMeta traits (Specific)Individual traits (Specific)
NEU.EXC_CT1,881All scopes362384
NEU.EXC_IT9,356All scopes411192
NEU.EXC_NTNG1268All scopes00
NEU.EXC_SYT2315All scopes4077
NEU.INH_LAMP5992All scopes263532
NEU.INH_PVALB1,936All scopes193183
NEU.INH_VIP3,087All scopes241366

State (L2)

35 canonical populations.

Type: neuron — State (L2)
BrowsersCell populationFull atlas cell countCell-to-scope referenceMeta traits (Specific)Individual traits (Specific)
NEU.EXC_CT.Ca2_sensor245All scopes00
NEU.EXC_CT.Ca2_signaling349All scopes6817
NEU.EXC_CT.projector823All scopes8726
NEU.EXC_CT.remodeling464All scopes231
NEU.EXC_IT.adhesion1,339All scopes252108
NEU.EXC_IT.callosal1,849All scopes286119
NEU.EXC_IT.guidance2,160All scopes27463
NEU.EXC_IT.neuromodulated979All scopes176116
NEU.EXC_IT.structural1,832All scopes17141
NEU.EXC_IT.transitional1,197All scopes237142
NEU.EXC_NTNG1.nuclear_reg143All scopes00
NEU.EXC_NTNG1.synaptic125All scopes00
NEU.EXC_SYT2.nuclear_reg121All scopes00
NEU.EXC_SYT2.synaptic194All scopes00
NEU.INH_LAMP5.exc_inh_balance411All scopes462
NEU.INH_LAMP5.glial_interface193All scopes00
NEU.INH_LAMP5.projecting200All scopes00
NEU.INH_LAMP5.rosehip188All scopes00
NEU.INH_PVALB.chandelier512All scopes1916
NEU.INH_PVALB.fastspike395All scopes2422
NEU.INH_PVALB.metabotropic165All scopes00
NEU.INH_PVALB.neuromodulatory106All scopes00
NEU.INH_PVALB.nuclear_reg531All scopes2512
NEU.INH_PVALB.serotonergic227All scopes00
NEU.INH_VIP.cannabinoid157All scopes00
NEU.INH_VIP.canonical_disinhibitory552All scopes5938
NEU.INH_VIP.develop_niche122All scopes00
NEU.INH_VIP.enkephalinergic77All scopes00
NEU.INH_VIP.excitatory_coupled263All scopes130
NEU.INH_VIP.LAMP5_hybrid251All scopes19
NEU.INH_VIP.matrix304All scopes2477
NEU.INH_VIP.nuclear_reg391All scopes204
NEU.INH_VIP.opioid394All scopes509
NEU.INH_VIP.regulatory_remodeling259All scopes61
NEU.INH_VIP.serotonergic317All scopes92

Membership reference version: 9b81aedc7b46066c709a4506c6c8d91ddea39c9faadf291d1f387158f8a904f7